Strategic rebrand for investment-propelled healthtech firm IMMJ Systems
The healthtech firm has also secured £1.8m investment from strategic investor Foresight and existing shareholders, to accelerate Mizaic’s vision to revolutionise the clinician : patient experience at the point of care.
Already home to more than 1 billion scanned images — and counting — Mizaic’s renowned product MediViewer is the EDMS of choice for more than 80,000 healthcare professionals and 16 million patients throughout the UK.
And now, having redefined not just the company’s name, but also its visual identity, mission, and proposition in the market, Mizaic’s CEO Jon Pickering has readied the rapidly-growing team to support an additional 20 Trusts over the next three years. This represents the potential to transform another 6 million structured, paper-based medical files, into indexable, informative, insightful and instant records, which provide a complete, connected picture of patients’ health.
Jon joined a newly-formed senior leadership team in late 2022, determined to better support the NHS on its journey to paperless. But the company’s relaunch very much represents a collective movement, he explained.
“While MediViewer has established a phenomenal reputation among Trusts in only seven years, we knew we were only scratching the surface of what’s possible, and needed, when it comes to the digitisation of the NHS,” he said. “So as we looked ahead to ‘what’s next’, we knew this was an opportunity to take our business from a hungry start-up, to an innovative yet established enabler of change.
“We have thoroughly researched everything from the competitive landscape, to our Trusts’ evolving needs, and of course, the opinions of the people who make everything happen — our staff. And we soon realised this project was about much more than a new identity for IMMJ Systems. It presented an opportunity to really boost the efforts of the healthtech ecosystem too.
“This is a complex environment, but with many colleagues having come from an NHS background, it’s a world we understand, in depth. So if we’re to drive much-needed EDMS adoption — and ensure MediViewer slots seamlessly into as many Trust workflows as possible — we needed to make the picture clear. This is what Mizaic is all about. The same great team, but even more potential.”
Mizaic’s chairman Graham Ridgway added: “We have a solid platform from which to invest across the business — in everything from software development to the strength of our company’s world-class services team. This means we can extend our NHS and private health sector coverage, while also better supporting the needs of our valued customers.”
And offering a concluding comment, Foresight’s senior investment manager, Lindsay Duebendorfer, said: “Mizaic is a fantastic example of Foresight’s model to back strong leadership teams with the vision and capability to deliver the business’ growth plan. Mizaic has built a market-leading position in healthcare technology, and like them, we are passionate about the markets we invest in. We look forward to supporting Mizaic through the next phase of growth.”